Histogram analysis of MR imaging-derived cerebral blood volume maps: combined glioma grading and identification of low-grade oligodendroglial subtypes
- PMID: 18583405
- PMCID: PMC8118772
- DOI: 10.3174/ajnr.A1182
Histogram analysis of MR imaging-derived cerebral blood volume maps: combined glioma grading and identification of low-grade oligodendroglial subtypes
Abstract
Background and purpose: Inclusion of oligodendroglial tumors may confound the utility of MR based glioma grading. Our aim was, first, to assess retrospectively whether a histogram-analysis method of MR perfusion images may both grade gliomas and differentiate between low-grade oligodendroglial tumors with or without loss of heterozygosity (LOH) on 1p/19q and, second, to assess retrospectively whether low-grade oligodendroglial subtypes can be identified in a population of patients with high-grade and low-grade astrocytic and oligodendroglial tumors.
Materials and methods: Fifty-two patients (23 women, 29 men; mean age, 52 years; range, 19-78 years) with histologically confirmed gliomas were imaged by using dynamic susceptibility contrast MR imaging at 1.5T. Relative cerebral blood volume (rCBV) maps were created, and 4 neuroradiologists defined the glioma volumes independently. Averaged over the 4 observers, a histogram-analysis method was used to assess the normalized histogram peak height of the glioma rCBV distributions.
Results: Of the 52 patients, 22 had oligodendroglial tumors. The histogram method was able to differentiate high-grade gliomas (HGGs) from low-grade gliomas (LGGs) (Mann-Whitney U test, P < .001) and to identify low-grade oligodendroglial subtypes (P = .009). The corresponding intraclass correlation coefficients were 0.902 and 0.801, respectively. The sensitivity and specificity in terms of differentiating low-grade oligodendroglial tumors without LOH on 1p/19q from the other tumors was 100% (6/6) and 91% (42/46), respectively.
Conclusion: With histology as a reference, our results suggest that histogram analysis of MR imaging-derived rCBV maps can differentiate HGGs from LGGs as well as low-grade oligodendroglial subtypes with high interobserver agreement. Also, the method was able to identify low-grade oligodendroglial tumors without LOH on 1p/19q in a population of patients with astrocytic and oligodendroglial tumors.
Figures






Similar articles
-
Multimodal MR imaging (diffusion, perfusion, and spectroscopy): is it possible to distinguish oligodendroglial tumor grade and 1p/19q codeletion in the pretherapeutic diagnosis?AJNR Am J Neuroradiol. 2013 Jul;34(7):1326-33. doi: 10.3174/ajnr.A3352. Epub 2012 Dec 6. AJNR Am J Neuroradiol. 2013. PMID: 23221948 Free PMC article.
-
Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.Clin Cancer Res. 2005 Feb 1;11(3):1119-28. Clin Cancer Res. 2005. PMID: 15709179
-
Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.AJNR Am J Neuroradiol. 2006 Oct;27(9):1975-82. AJNR Am J Neuroradiol. 2006. PMID: 17032878 Free PMC article.
-
Integrated diagnostics of diffuse astrocytic and oligodendroglial tumors.Pathologe. 2019 Jun;40(Suppl 1):9-17. doi: 10.1007/s00292-019-0581-8. Pathologe. 2019. PMID: 31025086 Review. English.
-
The role of imaging in the management of adults with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.J Neurooncol. 2015 Dec;125(3):457-79. doi: 10.1007/s11060-015-1908-9. Epub 2015 Nov 3. J Neurooncol. 2015. PMID: 26530262
Cited by
-
Glioma grade assessment by using histogram analysis of diffusion tensor imaging-derived maps.Neuroradiology. 2011 Jul;53(7):483-91. doi: 10.1007/s00234-010-0769-3. Epub 2010 Sep 21. Neuroradiology. 2011. PMID: 20857285
-
Clinical applications of susceptibility-weighted imaging in detecting and grading intracranial gliomas: a review.Cancer Imaging. 2013 Apr 24;13(2):186-95. doi: 10.1102/1470-7330.2013.0020. Cancer Imaging. 2013. PMID: 23618919 Free PMC article. Review.
-
Principles, techniques, and applications of T2*-based MR imaging and its special applications.Radiographics. 2009 Sep-Oct;29(5):1433-49. doi: 10.1148/rg.295095034. Radiographics. 2009. PMID: 19755604 Free PMC article. Review.
-
Imaging biomarkers of angiogenesis and the microvascular environment in cerebral tumours.Br J Radiol. 2011 Dec;84 Spec No 2(Spec Iss 2):S127-44. doi: 10.1259/bjr/66316279. Br J Radiol. 2011. PMID: 22433824 Free PMC article. Review.
-
Whole-tumor histogram analysis of the cerebral blood volume map: tumor volume defined by 11C-methionine positron emission tomography image improves the diagnostic accuracy of cerebral glioma grading.Jpn J Radiol. 2017 Oct;35(10):613-621. doi: 10.1007/s11604-017-0675-2. Epub 2017 Sep 6. Jpn J Radiol. 2017. PMID: 28879406
References
-
- Lev MH, Rosen BR. Clinical applications of intracranial perfusion MR imaging. Neuroimaging Clin N Am 1999;9:309–31 - PubMed
-
- Law M, Oh S, Babb JS, et al. Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging—prediction of patient clinical response. Radiology 2006;238:658–67 - PubMed
-
- Covarrubias DJ, Rosen BR, Lev MH. Dynamic magnetic resonance perfusion imaging of brain tumors. Oncologist 2004;9:528–37 - PubMed
-
- Edelman RR, Mattle HP, Atkinson DJ, et al. Cerebral blood flow: assessment with dynamic contrast-enhanced T2*-weighted MR imaging at 1.5 T. Radiology 1990;176:211–20 - PubMed
-
- Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994;191:41–51 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical